Iowa has recently joined 27 other states that have passed biosimilars legislation. On behalf of the 619,000 adults (plus 2,800 children) in Iowa with doctor-diagnosed arthritis, we’d like to thank Governor Branstad for signing House File 305 into law on Friday, March 10, 2017.
The bill allows Iowa pharmacists the ability to dispense safe and potentially less expensive biologic medications to patients, by substituting an FDA approved interchangeable biosimilar for a prescribed biologic product. The law also requires that the prescriber and patient be notified when there is a substitution.
Continue reading Victory in Iowa: Biosimilar Legislation Signed Into Law!
For years now, many arthritis patients have utilized biologic medications to great effect. Biologics have allowed those with arthritis, as well as many other chronic diseases, to stabilize their condition and help them better quality lives. Now, due to innovation, new medications are coming to market which could provide arthritis patients with more, and potentially less expensive, options. These new medications are called “biosimilar” medications which are similar to, but not exact copies of name brand biologics.
Continue reading Victory in Montana! Governor Bullock Signs Biosimilar Substitution
Imagine that your pharmacist substituted the biologic drug prescribed by your physician for a different drug, an interchangeable biologic product, without your physician being informed. For many people in Ohio who are taking biologic drugs, this scary scenario was a potential reality.
Continue reading Ohio Biosimilar Substitution bill signed into Law by Governor Kasich
With new, innovative arthritis medications coming to market, patients with arthritis may soon have access to potentially less expensive biosimilar medications. These are medications that are similar but not exact copies of name brand biologics.
Continue reading Biosimilar Substitution Victory in Hawaii!
Devon Salasin is a junior at Penn State University and a talented snow skier. So good, that she recently placed 23rd out of 107 skiers at the National Collegiate Alpine Race. But skiing wasn’t always fun or easy for Devon.
In 2011, Devon was diagnosed with juvenile rheumatoid arthritis (JRA). Overnight she went from a carefree kid pursuing her snow ski racing passion to a kid burdened with pain, swollen and deteriorating joints, and fatigue.
Continue reading Pennsylvania Arthritis Advocates Achieve Biosimilar Substitution Success!
Use of her hands meant everything. It’s how she saved lives. It’s how she provided for her family.
Susan Behen, MD, trained in general surgery at Johns Hopkins Hospital and held a specialty fellowship in colon surgery. For years she used her hands to perform all sorts of abdominal and laparoscopic surgeries. Then came the diagnosis – psoriatic arthritis.
Continue reading Arthritis Foundation Advocate Testifies Before U.S. Food and Drug Administration
School is out, so now what do you do to engage your kids? On June 29, a number of parents took their families to Harrisburg, PA, to participate in the 2016 Pennsylvania Advocacy and Access Day. Some of the youth were already pros having attended previous advocacy days and our Advocacy Summit in Washington, DC. For others it was a first time experience.
Continue reading Young Advocates in Pennsylvania Speak Out
Our advocacy team is incredibly active at the state level, leading the way to make sure that arthritis patients have access to critical medications. Our volunteer Advocates make a significant impact and help achieve tangible results by sharing their stories and asking elected officials to support legislation that is important to them and their families. But beyond fighting for key legislative changes and being vocal in raising awareness and sharing stories that help put faces with arthritis, we also make strides for the arthritis community when we link the voices of patient with the provider community – as we have done recently and successfully in New York and Ohio.
Continue reading Arthritis Foundation Collaborates with Providers at the State Level to Advocate for the Arthritis Community
Kyleigh O’Brien is an 11-year-old with juvenile arthritis and has testified in front of the Missouri legislature twice this year. Why does she do it?
She wants to be a voice for the estimated 300,000 children in the United States who live with arthritis. Kyleigh has advocated most recently for the passage of Missouri Senate Bill 875 (SB 875), which has now been signed into law by Governor Jay Nixon.
Continue reading Breaking Advocacy News in Missouri – Senate Bill 875 Regarding Biosimilars has Been Signed Into Law!
With new, innovative arthritis medications coming to market, patients with arthritis may soon have access to potentially less expensive biosimilar medications (similar to biologics).
However, imagine that, without your knowledge, your pharmacy substituted the biologic medication prescribed by your doctor with a new interchangeable biosimilar. Residents of Arizona no longer have to worry because this week, Arizona Governor Doug Ducey signed House Bill 2310 (HB 2310) into law. HB 2310 allows pharmacists to substitute biologic medications with new, interchangeable and potentially less expensive biosimilar medications when they come to market. The bill also ensures patients and their physicians know when a substitution occurs, resulting in a complete and accurate patient medical record. And, if physicians do not want a substitution to occur, they can stipulate that the prescription be dispensed as written.
Continue reading Arizona Arthritis Advocates Achieve Biosimilar Substitution Victory!